Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Aspirin has been demonstrated to be effective in inhibiting COX-2 and PGE2 in Alveolar macrophages (AMs). However,the mechanisms have not been fully understood. In the presentstudy, we found that pretreatment with aspirin inhibitedLPS-induced COX-2 and PGE2 upregulation, IκBα degradation,NFκB activation and the increase of PKC activity, but elevatedLPS-induced the decrease of PTP activity. The PKC inhibitorcalphostin C dramatically reduced the COX-2 mRNA andPGE2 levels, but the PTP inhibitor peroxovanadium (POV)significantly increased the COX-2 mRNA and PGE2 levels. Furthermore, the PTP inhibitor mitigated the inhibitory effectof aspirin on COX-2 and PGE2 upregulation and NF-κBactivation, whereas the PKC inhibitor enhanced the inhibitoryeffects of aspirin on the production of COX-2 and PGE2. Ourdata indicate a novel mechanism by which aspirin acts as apotent anti-inflammatory agent in alveolus macrophages andALI.
Abstract
Aspirin has been demonstrated to be effective in inhibiting COX-2 and PGE2 in Alveolar macrophages (AMs). However,the mechanisms have not been fully understood. In the presentstudy, we found that pretreatment with aspirin inhibitedLPS-induced COX-2 and PGE2 upregulation, IκBα degradation,NFκB activation and the increase of PKC activity, but elevatedLPS-induced the decrease of PTP activity. The PKC inhibitorcalphostin C dramatically reduced the COX-2 mRNA andPGE2 levels, but the PTP inhibitor peroxovanadium (POV)significantly increased the COX-2 mRNA and PGE2 levels. Furthermore, the PTP inhibitor mitigated the inhibitory effectof aspirin on COX-2 and PGE2 upregulation and NF-κBactivation, whereas the PKC inhibitor enhanced the inhibitoryeffects of aspirin on the production of COX-2 and PGE2. Ourdata indicate a novel mechanism by which aspirin acts as apotent anti-inflammatory agent in alveolus macrophages andALI.
참고문헌 (29)
- Leikauf, G. D., "Acute lung injury: functional genomics and genetic susceptibility", Chest, 121, pp.70S~75S (2002)
- Matute-Bello, G., "Animal models of acute lung injury", Am. J. Physiol. Lung. Cell Mol. Physiol, 295, pp.379~399 (2008)
- Rocco, P. R., "Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality?", Curr. Opin. Crit. Care, 14, pp.50~55 (2008)
- Sibille, Y., "Macrophages and polymorphonuclear neutrophils in lung defense and injury", Am. Rev. Respir. Dis, 141, pp.471~501 (1990)
- Hualin, C., "The anti-inflammatory mechanism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages", Inflammation, 35, pp.1087~1093 (2012)
- McCourtie, A. S., "Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation", Ann. Thorac. Surg, 85, pp.1056~1060 (2008)
- Gust, R., "Role of cyclooxygenase-2 in oleic acid-induced acute lung injury", Am. J. Respir. Crit. Care. Med, 160, pp.1165~1170 (1999)
- Dubois, R. N., "Cyclooxygenase in biology and disease", FASEB J, 12, pp.1063~1073 (1998)
- Goggel, R., "Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels", Am. J. Respir. Crit. Care. Med, 166, pp.657~662 (2002)
- Riese, J., "Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation", J. Leukoc. Biol, 55, pp.476~482 (1994)
- Jin, S. W., "Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1", Anesth. Analg, 104, pp.369~377 (2007)
- Looney, M. R., "Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury", J. Clin. Invest, 119, pp.3450~3461 (2009)
- Xu, X. M., "Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate", Proc. Natl. Acad. Sci. U. S. A, 96, pp.5292~5297 (1999)
- Keun-SangKwon, "Sodium Salicylate Inhibits Expression of COX-2 Through Suppression of ERK and Subsequent NF-κB Activation in Rat Ventricular Cardiomyocytes", Archives of Pharmacal Research, 26(7), pp.545~553 (2003), 대한약학회
- Mifflin, R. C., "Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts", Mol. Pharmacol, 65, pp.470~478 (2004)
- Giroux, M, "Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha", J. Immunol, 165, pp.3985~3991 (2000)
- Karin, M., "How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex", Oncogene, 18, pp.6867~6874 (1999)
- Yamaguchi, T., "Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation", J. Surg. Res, 178, pp.378~384 (2012)
- Wang, B., "Resolvin D1 protects mice from LPS-induced acute lung injury", Pulm. Pharmacol. Ther, 24, pp.434~441 (2011)
- Shin, Y. W., "Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis", Int. Immunopharmacol, 5, pp.1183~1191 (2005)
- Du, J., "Ginsenoside rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects", J. Immunol, 187, pp.942~950 (2011)
- Hsieh, H. L., "BK-induced COX-2 expression via PKC-delta-dependent activation of p42", p44 MAPK and NF-kappaB in astrocytes, 2007, pp.19, 330~340
- Liu, S., "p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway", Eur. J. Pharmacol, 584, pp.159~165 (2008)
- Xia, Y. F., "Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50", J. Immunol, 173, pp.4207~4217 (2004)
- Stark, L. A., "Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells", FASEB J, 15, pp.1273~1275 (2001)
- Muller, D. N., "Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage", FASEB J, 15, pp.1822~1824 (2001)
- Grilli, M., "Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation", Science, 274, pp.1383~1385 (1996)
- Wensvoort, G., "Mystery swine disease in The Netherlands: the isolation of Lelystad virus", Vet. Q, 13, pp.121~130 (1991)
- "J. Biol. Chem", 1995, 24995~25000
